Stocks and Investing Stocks and Investing
Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022

Matthew Harrison Maintained (BGNE) at Buy with Increased Target to $338 on, Apr 12th, 2022


Published on 2024-10-27 20:25:55 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $330 to $338 on, Apr 12th, 2022.

Matthew has made no other calls on BGNE in the last 4 months.



There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $177 on, Thursday, March 17th, 2022